Tonix Pharmaceuticals Holding Corp. conducted its annual meeting of shareholders on May 8, 2025. Shareholders approved several proposals during the meeting. Eight individuals were elected to the Board of Directors. The amendment to the Company's Amended and Restated Stock 2020 Stock Incentive Plan, increasing the number of shares available for awards, was approved. The 2025 Employee Stock Purchase Plan received approval. The authorization for the Board of Directors to effect one or more reverse stock splits within a specified range was also approved. Additionally, the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。